Philip R. Hamann

2.9k total citations
28 papers, 2.0k citations indexed

About

Philip R. Hamann is a scholar working on Organic Chemistry, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Philip R. Hamann has authored 28 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 13 papers in Molecular Biology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Philip R. Hamann's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Chemical Synthesis and Analysis (6 papers) and CAR-T cell therapy research (5 papers). Philip R. Hamann is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Chemical Synthesis and Analysis (6 papers) and CAR-T cell therapy research (5 papers). Philip R. Hamann collaborates with scholars based in United States, United Kingdom and Canada. Philip R. Hamann's co-authors include Lois M. Hinman, Janis Upeslacis, Arthur Kunz, Carl F. Beyer, Irwin Hollander, Nitin K. Damle, Erwin R. Boghaert, John F. DiJoseph, Maureen Dougher and David Flowers and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Blood.

In The Last Decade

Philip R. Hamann

28 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip R. Hamann United States 20 930 892 673 356 245 28 2.0k
Lois M. Hinman United States 15 551 0.6× 642 0.7× 664 1.0× 141 0.4× 97 0.4× 30 1.6k
Irwin Hollander United States 29 501 0.5× 342 0.4× 1.3k 2.0× 851 2.4× 284 1.2× 46 2.4k
John S. McMurray United States 31 1.1k 1.2× 255 0.3× 1.6k 2.4× 551 1.5× 199 0.8× 79 2.8k
Carolyn Discafani United States 23 1.4k 1.5× 357 0.4× 1.4k 2.1× 872 2.4× 205 0.8× 30 3.0k
Wayne C. Widdison United States 17 1.8k 1.9× 1.7k 1.9× 1.1k 1.6× 493 1.4× 85 0.3× 34 2.8k
Timothy B. Lowinger United States 20 843 0.9× 228 0.3× 1.3k 1.9× 742 2.1× 305 1.2× 53 2.7k
Laurie E. Grove United States 17 506 0.5× 191 0.2× 842 1.3× 102 0.3× 319 1.3× 35 1.6k
Hans K. Erickson United States 21 1.3k 1.4× 1.2k 1.4× 809 1.2× 207 0.6× 103 0.4× 43 2.1k
Rosalyn D. Blumenthal United States 32 810 0.9× 1.6k 1.8× 862 1.3× 145 0.4× 354 1.4× 95 2.9k
David W. Rusnak United States 17 2.3k 2.5× 947 1.1× 1.4k 2.2× 595 1.7× 108 0.4× 25 3.5k

Countries citing papers authored by Philip R. Hamann

Since Specialization
Citations

This map shows the geographic impact of Philip R. Hamann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip R. Hamann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip R. Hamann more than expected).

Fields of papers citing papers by Philip R. Hamann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip R. Hamann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip R. Hamann. The network helps show where Philip R. Hamann may publish in the future.

Co-authorship network of co-authors of Philip R. Hamann

This figure shows the co-authorship network connecting the top 25 collaborators of Philip R. Hamann. A scholar is included among the top collaborators of Philip R. Hamann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip R. Hamann. Philip R. Hamann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hollander, Irwin, Arthur Kunz, & Philip R. Hamann. (2007). Selection of Reaction Additives Used in the Preparation of Monomeric Antibody−Calicheamicin Conjugates. Bioconjugate Chemistry. 19(1). 358–361. 56 indexed citations
2.
Boghaert, Erwin R., Kiran Khandke, Latha Sridharan, et al.. (2007). Determination of pharmacokinetic values of calicheamicin-antibody conjugates in mice by plasmon resonance analysis of small (5 μl) blood samples. Cancer Chemotherapy and Pharmacology. 61(6). 1027–1035. 49 indexed citations
3.
DiJoseph, John F., Maureen Dougher, Douglas Armellino, et al.. (2006). Antitumor Efficacy of a Combination of CMC-544 (Inotuzumab Ozogamicin), a CD22-Targeted Cytotoxic Immunoconjugate of Calicheamicin, and Rituximab against Non-Hodgkin's B-Cell Lymphoma. Clinical Cancer Research. 12(1). 242–249. 103 indexed citations
4.
DiJoseph, John F., Maureen Dougher, Douglas Armellino, et al.. (2006). CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab. Cancer Immunology Immunotherapy. 56(7). 1107–1117. 42 indexed citations
5.
Hamann, Philip R., Lois M. Hinman, Carl F. Beyer, et al.. (2005). An Anti-MUC1 Antibody−Calicheamicin Conjugate for Treatment of Solid Tumors. Choice of Linker and Overcoming Drug Resistance. Bioconjugate Chemistry. 16(2). 346–353. 47 indexed citations
6.
Hamann, Philip R.. (2005). Monoclonal antibody–drug conjugates. Expert Opinion on Therapeutic Patents. 15(9). 1087–1103. 12 indexed citations
7.
Wissner, Allan, Philip R. Hamann, Ramaswamy Nilakantan, et al.. (2004). Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles. Bioorganic & Medicinal Chemistry Letters. 14(6). 1411–1416. 18 indexed citations
8.
DiJoseph, John F., Andrew G. Popplewell, Simon Tickle, et al.. (2004). Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22. Cancer Immunology Immunotherapy. 54(1). 11–24. 55 indexed citations
9.
10.
Hamann, Philip R., Lois M. Hinman, Irwin Hollander, et al.. (2001). Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Bioconjugate Chemistry. 13(1). 47–58. 431 indexed citations
11.
Hamann, Philip R., Lois M. Hinman, Carl F. Beyer, et al.. (2001). An Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Choice of Linker. Bioconjugate Chemistry. 13(1). 40–46. 147 indexed citations
12.
13.
Hartsell, Theresa L., Lois M. Hinman, Philip R. Hamann, & Nina F. Schor. (1996). Determinants of the response of neuroblastoma cells to DNA damage: the roles of pre-treatment cell morphology and chemical nature of the damage.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 1158–1166. 17 indexed citations
14.
Hinman, Lois M., Philip R. Hamann, Ryan M. Wallace, et al.. (1993). Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics.. PubMed. 53(14). 3336–42. 168 indexed citations
15.
Siegel, Marshall M., Irwin Hollander, Philip R. Hamann, et al.. (1991). Matrix-assisted UV-laser desorption/ionization mass spectrometric analysis of monoclonal antibodies for the determination of carbohydrate, conjugated chelator, and conjugated drug content. Analytical Chemistry. 63(21). 2470–2481. 65 indexed citations
16.
Hamann, Philip R. & Allan Wissner. (1989). The Efficient Synthesis of Two Prostaglandin Intermediates. Synthetic Communications. 19(9-10). 1509–1518. 4 indexed citations
17.
Ellestad, George A., Philip R. Hamann, Nada Zein, et al.. (1989). Reactions of the trisulfide moiety in calicheamicin. Tetrahedron Letters. 30(23). 3033–3036. 22 indexed citations
18.
Hamann, Philip R., et al.. (1988). Studies culminating in the total synthesis of (dl)-morphine. The Journal of Organic Chemistry. 53(20). 4694–4708. 55 indexed citations
19.
Bhagwat, Shripad S., Philip R. Hamann, & W. Clark Still. (1985). Synthesis of thromboxane A2. Journal of the American Chemical Society. 107(22). 6372–6376. 50 indexed citations
20.
Hamann, Philip R. & P. L. Fuchs. (1983). Conjugate addition of moderately soft anions to a vinyl sulfone. The Journal of Organic Chemistry. 48(6). 914–916. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lois M. Hinman Breakdown of academic impact, for papers by Irwin Hollander Breakdown of academic impact, for papers by John S. McMurray Breakdown of academic impact, for papers by Carolyn Discafani Breakdown of academic impact, for papers by Wayne C. Widdison Breakdown of academic impact, for papers by Timothy B. Lowinger Breakdown of academic impact, for papers by Laurie E. Grove Breakdown of academic impact, for papers by Hans K. Erickson Breakdown of academic impact, for papers by Rosalyn D. Blumenthal Breakdown of academic impact, for papers by David W. Rusnak
Rankless by CCL
2026